Abstract
Candida isolation from respiratory secretions rarely indicates invasive candidiasis and should not be treated with antifungal therapy. In contrast to pneumonia, colonization of the airway (or contamination of respiratory samples with oropharyngeal material) is extremely common. Whereas positive cultures from respiratory secretions are frequently used as indications to start antifungal therapy, multiple studies (including autopsies) consistently demonstrate poor predictive value at Candida isolation from lower respiratory secretions, including bronchoalveolar lavage (BAL). Diagnosis of Candida pneumonia requires histopathologic confirmation. Due to the extremely common finding of Candida in respiratory secretions, the lack of specificity (even using bronchoscopy) and the rarity of Candida pneumonia, a decision to treat with antifungal agents should never be based merely on respiratory tract cultures. Candida pneumonia (and lung abscess) is extremely uncommon.
Supported in part by CIBERES 06/06/0036, AGAUR 09/SGR/920
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Daly JS, Finberg RW (2008) Acute infection in the immunocompromised host. In: Irwin RS, Rippe JM (eds) Irwin and Rippe’s intensive care medicine, 6th edn. Lippincott Williams & Wilkins, Philadelphia
von Eiff M, Roos N, Fegeler W et al (1996) Hospital-acquired candida and aspergillus pneumonia – diagnostic approaches and clinical findings. J Hosp Infect 32:17–28
Galvan B, Mariscal F (2006) Epidemiologia de la candidemia en UCI. Rev Iberoam Micol 23:12–15
Vélez L, Correa LT, Maya MA et al (2007) Diagnostic accuracy of bronchoalveolar lavage samples in immunosuppressed patients with suspected pneumonia: analysis of a protocol. Respir Med 101:2160–2167
Rossini F, Verga M, Pioltelli P et al (2000) Incidence and outcome of pneumonia in patients with acute leukemia receiving first induction therapy with anthracycline-containing regimens. Haematologica 85:1255–1260
Pappas PG, Rex JH, Sobel JD (2004) Infectious diseases Society of America. Guidelines for treatment of candidiasis. Clin Infect Dis 38:161–189
Kishikawa H, Tojima H, Tokudome T (1997) Microscopic polyangiitis and pulmonary fibrosis in a patient who died of Candida pneumonia and intra-alveolar hemorrhage. Nihon Kyobu Shikkan Gakkai Zasshi 35:915–920 [Japanese – Abstract]
Martin GS, Mannino DM, Eaton S et al (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546–1554
Trick WE, Fridkin SK, Edwards JR et al (2002) National Nosocomial Infections Surveillance System. Secular trend of hospital-acquired candidemia among intensive care unit patients in the united states during 1989–1999. Clin Infect Dis 35:627–630
Mohsenifar Z, Chopra SK, Johnson BL et al (1979) Candida pneumonia: experience with 20 patients. West J Med 131: 196–200
Haron E, Vartivarian S, Anaissie E et al (1993) Primary Candida pneumonia. Experience at a large cancer center and review of the literature. Medicine (Baltimore) 72:137–142
Masur H, Rosen PP, Armstrong D (1977) Pulmonary disease caused by Candida species. Am J Med 63:914–925
Schröter GP, Hoelscher M, Putnam CW et al (1977) Fungus infections after liver transplantation. Ann Surg 186: 115–122
Buff SJ, McLelland R, Gallis HA et al (1982) Candida albicans pneumonia: radiographic appearance. AJR Am J Roentgenol 138:645–648
Petrocheilou-Paschou V, Georgilis K, Kontoyannis D et al (2002) Pneumonia due to Candida krusei. Clin Microbiol Infect 8:806–809
Menezes AV, Sigesmund DA, Demajo WA et al (1994) Mortality of hospitalized patients with Candida endophthalmitis. Arch Intern Med 154:2093–2097
Pittet D, Monod M, Suter PM et al (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220:751–758
Bär W, Hecker H (2002) Diagnosis of systemic Candida infections in patients of the intensive care unit. Significance of serum antigens and antibodies. Mycoses 45:22–28
Voss A, Hollis RJ, Pfaller MA et al (1994) Investigation of the sequence of colonization and candidemia in nonneutropenic patients. J Clin Microbiol 32:975–980
Almirante B, Rodríguez D, Park BJ, Barcelona Candidemia Project Study Group et al (2005) Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003. J Clin Microbiol 43: 1829–1835
Sickles EA, Greene WH, Wiernik PH (1975) Clinical presentation of infection in granulocytopenic patients. Arch Intern Med 135:715–719 [Abstract]
Vincent JL, Anaissie E, Bruining H et al (1998) Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med 24:206–216
Yeo SF, Zhang Y, Schafer D et al (2000) A rapid, automated enzymatic fluorometric assay for determination of D-arabinitol in serum. J Clin Microbiol 38:1439–1443
Allaouchiche B, Coronel B, Gagnieu MC et al (2004) Cytokine levels in bronchoalveolar lavage fluid and blood of neutropenic patients with pneumonia. Bull Cancer 91: 77–80
Petri MG, König J, Moecke HP, Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research et al (1997) Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Intensive Care Med 23:317–325
De Bellis P, Bonfiglio M, Gerbi G et al (2003) High-dose fluconazole therapy in intensive care unit. Minerva Anestesiol 69:145–152
Heussel CP, Kauczor HU, Heussel GE et al (1999) Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography. J Clin Oncol 17:796–805
Syrjälä H, Broas M, Suramo I et al (1998) High-resolution computed tomography for the diagnosis of community-acquired pneumonia. Clin Infect Dis 27:358–363
Weinberger M, Sacks T, Sulkes J et al (1997) Increasing fungal isolation from clinical specimens: experience in a university hospital over a decade. J Hosp Infect 35:185–195
Azoulay E, Timsit JF, Tafflet M et al (2006) Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia. Chest 129:110–117
El-Ebiary M, Torres A, Fàbregas N et al (1997) Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study. Am J Respir Crit Care Med 156:583–590
Rello J, Esandi ME, Díaz E et al (1998) The role of Candida sp isolated from bronchoscopic samples in nonneutropenic patients. Chest 114:146–149
Penack O, Beinert T, Buchheidt D, German Society of Hematology and Oncology et al (2006) Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 85: 424–433
Benoit DD, Vandewoude KH, Decruyenaere JM et al (2003) Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit Care Med 31: 104–112
Garnacho-Montero J, Díaz-Martín A, Cayuela-Dominguez A (2008) Management of invasive Candida infections in non-neutropenic critically ill patients: from prophylaxis to early therapy. Int J Antimicrob Agents 32(Suppl 2): S137–S141
Deray G (2002) Amphotericin B nephrotoxicity. J Antimicrob Chemother 49(Suppl 1):37–41
White MH, Bowden RA, Sandler ES et al (1998) Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia. Clin Infect Dis 27:296–302
Eriksson U, Seifert B, Schaffner A (2001) Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial. BMJ 322:579–582
Ellis ME, al-Hokail AA, Clink HM et al (1992) Double-blind randomized study of the effect of infusion rates on toxicity of amphotericin B. Antimicrob Agents Chemother 36: 172–179
Chen H, Suda KJ, Turpin RS et al (2007) High- versus low-dose fluconazole therapy for empiric treatment of suspected invasive candidiasis among high-risk patients in the intensive care unit: a cost-effectiveness analysis. Curr Med Res Opin 23:1057–1065
Pappas PG, Kauffman CA, Andes D et al (2009) Infectious Diseases Society of America. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48:503–535
Mora-Duarte J, Betts R, Rotstein C, Caspofungin Invasive Candidiasis Study Group et al (2002) Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 347:2020–2029
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Carvajal, C., Rello, J., Lipman, J. (2011). Candida Pneumonia in Patients with Hematological Neoplasia. In: Azoulay, E. (eds) Pulmonary Involvement in Patients with Hematological Malignancies. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-15742-4_28
Download citation
DOI: https://doi.org/10.1007/978-3-642-15742-4_28
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-15741-7
Online ISBN: 978-3-642-15742-4
eBook Packages: MedicineMedicine (R0)